P-343 The impact of genomic alterations on response rate and survival outcomes in advanced BTC patients who receive cisplatin/gemcitabine plus durvalumab in clinical practice

M. Rimini,M. Rizzato, L. Rimassa,M. Niger,L. Fornaro,L. Antonuzzo, E. Martinelli, I. Garajová, A. Pastorino, G. Giordano,M. Schirripa, M. Silletta, A. Diana,A. Casadei Gardini

Annals of Oncology（2023）

引用 0|浏览2

暂无评分

关键词

advanced btc patients,cisplatin/gemcitabine,durvalumab,survival outcomes,cisplatin/gemcitabine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要